|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.064
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.057
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.049
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.047
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.045
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
3 |
0.045
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.044
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.043
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.042
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.042
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.041
|
|
|
positive regulation of syncytium formation by plasma membrane fusion
|
GO:0060143 |
17 |
0.039
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.039
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.038
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.037
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.036
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.034
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.034
|
|
|
ossification
|
GO:0001503 |
216 |
0.032
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.032
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.032
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.031
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.031
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.031
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.030
|
|
|
protein processing
|
GO:0016485 |
163 |
0.030
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.030
|
|
|
nk t cell proliferation
|
GO:0001866 |
2 |
0.029
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
cation transport
|
GO:0006812 |
399 |
0.029
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.029
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.029
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.028
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.027
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.027
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.026
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.026
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.026
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.026
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.025
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.025
|
|
|
skin development
|
GO:0043588 |
220 |
0.025
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.025
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.024
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.024
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.024
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.023
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.023
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.022
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.022
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.022
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.021
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.021
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.021
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.021
|
|
|
action potential
|
GO:0001508 |
78 |
0.021
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.021
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.021
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.020
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.020
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.020
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.020
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.019
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.019
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.019
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.019
|
|
|
positive regulation of b cell chemotaxis
|
GO:2000538 |
2 |
0.019
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.019
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.018
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.018
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.018
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.018
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.018
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.018
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.018
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.018
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.017
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.017
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.017
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.017
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.017
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.017
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
negative regulation of macrophage activation
|
GO:0043031 |
2 |
0.017
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.016
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.016
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.016
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.016
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.016
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.016
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.015
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.015
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.015
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.015
|
|
|
lung development
|
GO:0030324 |
164 |
0.015
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.015
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.015
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.014
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.014
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.014
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.014
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.014
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.014
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.014
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.014
|
|
|
regulation of b cell chemotaxis
|
GO:2000537 |
2 |
0.014
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.014
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.014
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.014
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.014
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.014
|
|
|
limb development
|
GO:0060173 |
166 |
0.014
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.014
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.014
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.014
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.013
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.013
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.013
|
|
|
gland development
|
GO:0048732 |
330 |
0.013
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.013
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.013
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
neutrophil mediated killing of gram negative bacterium
|
GO:0070945 |
4 |
0.013
|
|
|
positive regulation of myotube differentiation
|
GO:0010831 |
24 |
0.013
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
organ growth
|
GO:0035265 |
117 |
0.013
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.013
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.013
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.012
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.012
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.012
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.012
|
|
|
alpha beta t cell proliferation
|
GO:0046633 |
21 |
0.012
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.012
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.012
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.012
|
|
|
natural killer cell chemotaxis
|
GO:0035747 |
1 |
0.012
|
|
|
detection of peptidoglycan
|
GO:0032499 |
1 |
0.012
|
|
|
mature natural killer cell chemotaxis
|
GO:0035782 |
1 |
0.012
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.012
|
|
|
regulation of systemic arterial blood pressure by atrial natriuretic peptide
|
GO:0003050 |
2 |
0.012
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.012
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.012
|
|
|
wound healing
|
GO:0042060 |
157 |
0.012
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.012
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.012
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.012
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.012
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.011
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.011
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.011
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.011
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.011
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.011
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.011
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.011
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.011
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.011
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.011
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.011
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.011
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.011
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.011
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.011
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.011
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.011
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.011
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.011
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.011
|
|
|
glucosamine containing compound metabolic process
|
GO:1901071 |
3 |
0.011
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.010
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.010
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.010
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.010
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.010
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.010
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.010
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.010
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.010
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.010
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.010
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.010
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.010
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.010
|
|